Note: Descriptions are shown in the official language in which they were submitted.
BREAST PROSTHESIS
.
BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
_
This invention rclates to new and useful improve-
ments in a breast prosthesis suitable for implantation in a
human breast for recon~tructive or cosmetic purposes.
BRIEE DESCRIPTION OF THE PRIOR ART
Surgical reconstructiQn of human breasts as a result
of injury or as a result of partial or total maStectQmy has
been perfQrmed for many years. In recent years, surgical
augmentation of breasts has particularly become CQmmOn for
cosmetic purposes in cases of breast hypoplasia. Over the
past 10-15 years, various surgical prostheses have been de-
veloped for implantation in the human brea~t as a part of
breast reconstruction or augmentation. Recently developed
prostheses have been satisfactory in some cases but in a
substantial number of other cases significant degrees Qf
capsular tightness or co~tracture has developed causing un-
desirable appearance associated with some pain and dis-
comfort.
Surgical pr~cedures for breast r~o~struction aredescribed in detail in the medical literature, particularly
in Journals dealing with plastic surgery. Some of this lit-
erature de~cribes pro~thethic devices which are in common
use. 1'he recently published textbook RECONSTRUCTIVE PLASTIC
SURCERY, CONVERSE, 1980, pp. 3694-3704 gives a thorough
review of the history ~f the development of breast
prostheses and of the prob~ems involved. PLASTIC SURGERY,
~9~
WILLIAM C. CRABB AND JAMES W. SMITH, 1979 is another text
giving a thorough treatment of this subject. Representative
medical journal references, listed somewhat in order of
relevanoe and importance, are: PLASTIC AND RECONSTRUCTIVE
SURGERY, December 1976, pp. 689-693; Auguqt 19?2, pp.
107-113; November 1976, pp. 555-560; August 1976,. pp.
137-141; January 1980, pp . 30-33; November l977, pp.
720-724; August 1979, pp.151-155; July 1980, pp.71-73; June
1977, pp.849-850; March 1980, pp. 302-306; and AESTHETIC
l0 PLASTIC SURGERY, 1979, 3:339-341; 1978, 2:435~441; and 1978,
2 : 217-234.
Most of the prior art Qn the physical structure of
breast prostheses, however, is f~und in the patent literat-
ure, particularly the United States patents relating to that
subject. The patent literature includes many experimental
and non-commercial pro~theses aq well as ~nes which have had
~ub~tantial medical usage. The following patents represent a
summary of the most pertinent ~atent art dealing with breast
pro~theses.
Cronin U.S. Patent 3,293,663
Hartley U.S. Patent 3,934,274
Pangman U.S. Patent 2,842,775
Pangman U.S. Patent 3, 366,975
Pangman U.S. Patent 3,559, 214
Pangman U.S. Patent 3,683,424
Boone U.S. Patent 3,600,718
Mohl et al U.S. Patent 3,663,968
Perras et al U.S. Patent 3,665,520
- Perras U.S. Patent 3,681,787
1~91(~
McGhan et al U.S. Patent 3,852,832
Koneke et al U.S. Patent 3,852,833
Lynch U.S. Patent 3,883,902
Sanders et al U.S. Patent 3,919,724
Lynch U.S. Patent 3,986,213.
Cresswall U.S. Patent 4,035,850
. .
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a partial section through a female human
breast showing a prior art type of prQsthesis at or shortly
after the time of surgical implantation.
Figo 2 is a sectional view of the surgical implant-
ation shown in Fig. 1 at a later time after initial forma-
tion of a tissue encap~ulation.
Fig. 3 is a sectiQnal view similar t~ that ~hown in
Fig. 2 illu~trating the condition of the prosthesis after
full formation and contraoture of the tissue encapsulation.
Fig. 4 is an isometric view of a breast prosthesis
representing a preferred embodiment Gf thi3 invention.
Fig. 5 i~ a sectional view taken on the line 5 5 of
Fig. 4.
Fig. 5A is a fragment~ry view in section similar to
Fig. 5 showing an alternate embodiment in which the outer
lumen of the prosthesis does not overlap_the back wall of
the inner core or permanent cGmponent of the~prosthesis.
Fig. 6 i9 a secti~nal view of a breast similar to
thst ~hown in Fig~ 1 sh~wing the prosthesis of Fig. 4 at the
time of implantation.
Fig, 7 is a sectional view of the prosthesis as im-
planted in accordance with Fig. 6 after formatiQn of the
tis~ue encap~ulation.
~91~
FiK. 8 is a sectional view of the prosthesis a~
shown in Fig. 7 after the outer sac has been absorbed~
Fig. 9 i9 a sectional view, similar tQ that shown in
Fig. 5, of an0ther embodiment of the breast prosthesi~ of
thi~ invention.
Fig. 10 i~ a ~ecti4nal view, similar to that shown
in Fig. 6, of still another embQdiment ~f the breast pros-
theYl~ of thi invention.
Fig. 11 is a secti~nal view, similar to that shown
in Fig. 5, of an embodimenS in which the core or permanent
part of the prosthesis is of a dQuble lumen construction.
Fig. 12 is a sectional view of a breast with the
prosthesis of Fig. 11 implanted therein.
Fig. 13 i9 a sectional view of a prosthesis similar
to that of Fig. 11 in which the c~nnection of the absorbable
outer component tQ the core c~mp~nent i9 as shown in Fig.
5a.
ANALYSIS OF THE_P OBLEM
Since the development of the first prostheqi~ u2ed
in breast augmentation and recon3tructive surgery, tightne~s
and contracture of the fibrou~ capsule f~rmed around the
prosthe~is have been serious problems. Studies show that
35S - 40~ of patients who undergo brea~t augmentation devel-
op significant degrees of capsular tightnes~ or contracture
which in YOme cases cau~e~ pain and discom~4rt. Tightness
and capsular contracture have caused augmented or reCQn-
3tructed breasts t~ have unnatural spherical appearance and
to feel hard and undesirable to the touch and palpation.
Con~equently, the patients as well as surgeon~ have been
les~ than happy with the result~.
~91~0~
Various clinical and lab~ratory research has been
conducted over the last 10-15 years trying to find a solut-
ion to the pr~blem. Although significant impr~vements have
been acc~mplished in the quality of the prosthesis itself,
the problem of capsular contraction has n~t changed
appreciably. Several techniques and methods and newer pros-
theses have been designed and used ln an attempt tu imprQve
and mitigate the problem of capsular contracture. These
techniques have been generally unsuccessful and have been
either completely abandoned or used ~ith less enthusiasm.
The problem continues tc the present day9 see any of the
recent publications listed above.
Up to thi~ date, the 0nly available way to remedy
the capsular contracture has been by surgery. The
operation, which is called surgical capsulutomy and
capsulectomy, am~unts to incising and removing the
contracted capsule and implant and inserting either the same
or another implant. This operation, of c~urse, may have the
~ame fate as the original ~ne and the same problem of
capsular contracture may come ab~ut all over again.
~ he problem o~ capsular contracture can be
understs~d more clearly by reference to Figs. 1 and 2 of the
drawings. In Fig. 1, there i9 shown a detail view in part-
ial section of a human female breast 1 which has a typical
prior-art-type breast prQsthesis 2 implan~ed therein. The
prosthesis 2 is preferably a flexible container ur sac 3 of
a suitable thin walled or film material such as silicone
rubber enclosing a core of a ~oft or fluid or malleable mat-
erial. Core 4 is preferably of a silicone gel or other
suitable material which pr~vides fur malleability or plas-
ticity and yet is not unduly sQft.
When a foreign body is implanted in human or animal
tissues, the tissue~ form a fibrous capsule around the for-
eign body to protect the 3urrounding tissues. The encapsul-
ation i~ a defen~ive mechanism and is somewhat similar to
the formation of sear tissue in the healing of a wound er
~urgical incision. In Fig. 2 of the drawing~, the condition
of the implanted pr~sthesis 2 is seen after a period of time
when pro~thesi~ 2 has fir~t become encap~ulated. The encap-
sulation is indicated at 5 and represents a fibrous tissue
eapsule as sh~wn schematically in Fig. 2.
~ ibrous tissue eap~ule 5 completely encloses the im-
planted prQsthesis 2 and contracts around prosthesis 2 to
cause the prc~thesis to be c~mpressed tightly. The con-
tracture 0f eapsule 5 around prosthesis 2 results in the
prosthesi~ developing a feel of being very hard and rigid,
and ultimately as~umes a nearly spherical ~hape as illust-
rat~d in Fig. 3. The formatiGn of this hard, encapsulated
pro~thesis iY a 3erious condition bQth from medical and
~sthetic ViewpQintS. It is thi~ condition which has been
discu~3ed above and whieh the prior art techniques have
failed to cure.
The problem of capgular eontracture is very eo~plex.
TQ find a solution tQ this problem~ a number of physiolog-
ieal and physiopathologieal ~aets have been considered. It
i~ well known that the formation of fi~rouY conneetive
ti~sue as a capsule ar~und an implant or ar~und any foreign
body is a natural phenomenon. Such a capsule will form
regardles~ of the physieal or chemical structure of the
foreign body. ~he normal tis~ue9 ~urr~unding the foreign
body or implant are reaetive toward the intruder and will
-lay down fibrous tissues which form the capsule. TQ date,
- 7 -
~91~Gl
there has been no way tQ prevent the formation ~f the fib
r~us capsule around implants or prosthese3 or other foreign
bodies.
A fibrous cap3ule always f~rms around implants or
pro~these3 or foreign bodies in an intimate fashion conf~rm
ing to their respective shapes and curvatures. The capsule
tend~ to contract tightly around the foreign b~dy being en-
capsulated. The intimacy of fibrous tissue formation-around
a foreign body, which by existing techniques is inevitable,
i~ the key factor in the formation Qf a tightly contracted
fibrous capsule. Once the capsule has fo,med, it is
permanent. That is, it will not dissolve or disintegrate by
itself or by the enzymes or natural fluids of the body.
Also, there is n~ physical or chemical agent presently
available that can be used t~ alleviate the tightness of the
cap~ule.
After careful consideratiQn of the factors discussed
above relating t~ the nature of the process of formation of
the fibrou~ capsule it was concluded that the only factor in
the encapsulation proces~ which can be altered is in the re~
lationship of the capsule tG the implanted prosthesis. It
waY concluded that alteration of the po~ition ~f the fibrou3
capsule realtive to the implanted prosthesis would prevent
the formati0n of a tightly contracted capsule.
This inventi~n, therefor, represents a newly design-
ed technique, utilizing a prosthesis of novel construction,
whereby the capsule is forced t~ form at a c~ntrolled
distance from the implanted pro~thesis rather than intimat-
ely close tQ it. This solve~ the problem completely since
there i~ enou~h leeway between the implanted prosthesis and
-the fibrous capsule SQ that the problem of tightness or
c~ t-racture is avoided. Thls is the essence of the invention.
DESCRIPl:'ION C)F TXE PREFE~RED_EMBODIMENTS
The invention consists of a two-phase breast prosthesis
comprising an inner permanent core of biologically compatible,
non-absorbable material surrounded by means to effect capsule
formation at a selected and controlled distance therefrom and
without contractive pressure thereon after surgical implantation.
In another embodiment, the invention very simply contem-
plates a breast prosthesis which comprises an inner coherent core
of biologically compatible, non-absorbable material and an outer
covering of absorbable material having an outer surface spaced
from the surface of the core.
The first phase or outer segment is temporary and consists
of a flexible walled container or bag of a material which is
absorbable or can be rendered absorbable under conditions of use.
The second phase or inner segment is permanent and consists of a
core which is smaller -than and contained in the outer bag or
container. The inner core is preferably a smaller container or
bag which is made of a non-absorbable material, such as a silicone
rubber film, and contains a suitable filler, such as a normal
saline solution or silicone gel or any other malleable or plas-tic
or fluid material. The space surrounding the core inside the
outer bag or container is preferably filled with a saline solutlon.
The distance between the outer container and the inner core can
be exactly designed at a controlled measurement and is effective
to cause the formation of the fibrous capsule at the same distance
from the permanent implanted prosthesis.
MATERIALS OF CONSTRUCTION
As noted above, the outer container or sac is a film
or thin walled material or coating which is absorbable under
conditions of use or can be rendered absorbable under con-
ditions of use. An "absorbable material", as that term :is
u~ed herein, is defined as any material which is biological-
ly acceptable and, under the conditions of use, can be
absorbed by the body tissues, i.e. dlssolved or
disintegrated and removed by the body. This definition
includes materials which are recognized in the medical
literature as beinB absQrbaDle; materials which have known
or readily determined properties permitting absorpticn or
di~oluti~n by the body; and materials which can be treated
at the time of manufacture, or prior to, during, or
subsequent t~ surgical implantation to render them capable
0f absorption cr dissolution or the like.
These materials may be absorbed by phagocytosis,
enzymatic decomposition, di3solution~ hydrolysis, etc. under
conditions existing naturally in the b~dy. Alternatively,
materials can be used, which are within this definition of
absorbable material~, which are absQrbable by reason of
chemical or physical treatment at the time of manufacture or
prior to, duringr or subsequent to surgical implantation.
This would include materials which are not
them~elves absorbable but which are or become absorbable
under conditi~ns of use. Thus, regenerated cellulQse is not
itself absorbable but can be rendered ab~orbable by
treatment with the enzyme cellulase, Similar enzymes, e.g.
proteinase, collagenase, amylase, etc., are kn~wn which will
decompose protein, collagen, and amylos~ materials. Also,
s~me protein materials degenerate at certain conditions of
pH. It i3 thus apparent that the outer container can be
formed of materials which are n~t themselves absorbable, but
which can be treated, as by addition of chemical~ or enzymes
to the materi~l~ or to the fluid inside or surroundinK the
outer container to render such materials abs~rbable.
- 10 -
,
~91~
Materials which can be rendered absorbable in this or
similar manner are considered t~ be within the above
definition ~f absorbable materials.
The initially preferred materials are ones which
have had a long established use in surgery, particularly
suture materials including properly processed and sterilized
animal gut, collagenou~ materials, and synthetic suture mat-
erials such a polyglyco~ic acid, polyglactin 910, reconqti-
tuted collagen, etc. Synthetic films which may be used
include synthetic protein film or sheet material made of
reconstituted collagen or reconstituted animal or vegetable
protein or the like. Other synthetic absorbable materials
which may be used include films of absorbable polyesters,
such as condensation polymers ~f hydroxy-organic acids, e.g.
polylactic acid, p~lyglyc~lic acid, polyglactin 910, etc.,
and low molecular weight polyesters of glycols cr cther
polyols and diba~ic or p~ly~asic acids, e.g~ pQlyesters of
~uccinic acid (succinic acid polyesters as bioabsorbable
material~ are described in Coquard et al U.S. Patent
3,883,gol).
In addition, films may be used which are of natural-
ly occurring materials or derivatives therecf, which have a
very low solubility in water. Suitable films include starch
films, amylose films, films of cellulvse derivatives, such
a~ methyl cellulose, ethyl cellulose, hydroxyethyl cellu-
lose, carboxymethyl cellulose, etc. In ~he case of these
films of carbohydrates or carboydrate derivatives, it should
be noted that the i~pQrtant characteristic required is that
the film have only a very ~light solubility in water. These
materials are nontoxic and the ones that are very slightly
soluble in water will be dissolved slcwly and removed over a
~91~0~
pericd of time~ Similar materials can be used which are not
soluble or absorbable but which are rendered soluble or ab-
~orbable by incorpQration cf a suitable chemical cr enzyme
~r by a further chemical ~r enzymatic ~r physical treatment.
MECHAN_ M OF FUNCTION OF INV~NTION
When this twc-phase prosthesis is implanted, the
fibrcus capsule will form around the phase one ~r outer
temporary container which is at a distance from the core
which represents the phase two or permanent part of the
pro~thesis. Over a periQd of time, the outer bag 4r
container will be absGrbed by the body leaving behind a
fibrous capsule which is larger than, and not intimately
attached to, the inner core or nonabsorbable implant. The
distance between the formed cap~ule and the permanent
prQ~thesis can be exactly predetermined at the time of
construction by p~siti~ning the outer absorbable layer at
the optimum and de~ired space from the inner n~n-absorbable
permanent core. This will al1 be described in more detail in
connecti~n with the several specific examples of the improv-
ed breast prosthesis which i~ to be described below.
In Fig. 4 there is shown an isometric view of an im-
proved, surgically-implantable breast prosthesis 12 which
represents a preferred embQdiment of the invention. In Fig.
5, brea~t prosthesis 12 is shown in sectional view alcng a
center line thereof t~ illustrate the two-phase construct-
ion. Breast prQsthesis 12 c~nsits ~f an inner core 13 of
biol3gically acceptable ~.aterial. Core 13 is preferably a
~ac or container 14 of a film or thin-walled flexible mater-
ial, such as sllicone rubber and is filled with a liquid or
fluid or plastic substance 15. The filler material 15 is
-preferably a silicone gel or may be a liquid, such as a
- l2 -
,
llglO~
sterile saline s~lution. Other malleable or pla~tic ~r
~emifluid materials may be used t~ fill the sac or container
14 a~ l~ng as they are sterile, nontoxic and of 1QW density.
rhe core 1~ of breast prasthesis 12 is enclo~ed in
an ~uter ~ac or container 16 of a thin-walled flexible
material or film of a bioab~orbable material. The rear wall
of core 13 may be c4mpletely cov2red by outer lumen ~r sac
16, as seen in Fig. 5~ or the ~uter lumen or sac 16 may be
sealed to the edge of the rear wall as indicated at 26 in
l~ Fig. 5A. In the embcdiment of Fig. 5A, the exposed rear wall
of c~re 13 may be prcvided with a fabric patch or cover as
in the prosthesis of Cronin. The space inside the sac or
container 16 and surrounding the core 13 is filled with a
-~uitable biologically acceptable liquid or an absorbable
sponge 17.
In the prosthesis, as shown and described in Figs.
4, 5 and SA, the outer container Qr ~ac 16 is of any suit-
able absorbable film or thin walled material. Such absorb-
able material is a material as defined above and should be
capable of preparation in a form which can be used in
~urgical $mplantation. The mechanism of absorption of the
ab30rbable material depends up0n the particular material
u~ed.
Thus, gut and protein or collagenous films are gen-
erally ab~orbed by phagccytosis. Po1yesters and polymers
such as polyglycolic acid~ polylactic acid, polyglactin 910,
etc. are absorbed by hydrolysis and dissoluti~n of the hy-
drolysi~ products. Amylose and certain cellulose derivatives
are absQrbable by slQw dis~olutiQn.
- 13 -
~.9~
Other films~ including cellulose and certain protein
film9, can be absorbed by enzymatic attack cr by physical or
- chemical decompositi~n. In the case of materials which are
rendered absorbable under conditi~n~ of use the enzymes or
other chemicals required can be added directly tc the film
material or can be inc~rporated into the fluid inside the
outer c~ntainer at the time of manufacture Qr at a later
date ~including introducti~n by hypodermic needle after sur-
gical implantation) or can be in~tilled in the surgical
cavity.
While the outer temp~rary sac or container 16 is of
a nontoxic abs~rbable material, the inner permanent c~re 13
i4 of a biologically acceptable or compatible non-absorbable
mat~rial and is preferably a sac 14, as previQusly
described, of a biologically acceptable or compatible film
or covering ~r coating material, silicQne rubber being a
preferred material. The filler material 15 within the core
i~ preferably a gel ~r semisolid, ~uch as silicone gel cr a
liquid, such as a saline ~olution or other similar material.
The inner core c~uld alsQ be filled with a powdered
or granular material 2~ as ~hown in Fig. 10, all of the
other compQnents being the ~ame as shcwn in Figs. 4 and 5.
In such embodiment, the granular material wculd have to be a
very low density material which is sterile and nontoxic and
biols~ically acceptabl`e. A finely divi~ed cellulQse or
microspheres ~f gla~s or phenolic resin could be u~ed for
this purpose. Another embQaiment which would function sat-
isfactorily, i9 ~hown in Fig. 9, in which the c~re 13 is ~f
a sponge material 35 which is biclQgically acceptable and
which may be provided with cr with~ut the inner sac 14 cov-
ering the core. The remaining structure 4f the pro~thesis
- 14 -
shown in Fig. 9 is the ~ame as shown and described in Figs~
4 and 5 and any of the defined materials 4f construction can
be u3ed.
In Figs. 6 to 8 0f the drawings, there is illustrat-
ed the result~ of the implantation ~f the prosthesis of thi~
invention in a human female breast. In ~ig. 6, the pros-
thesi~ shown in Figs. 4 and 5 (or the prosthesis of Fig. 9
or Fig. 1G) is shown at the time ~f original implantation.
Prosthesis 12 is shown ir section and in the view ~hown in
~ig. 6 is essentially the same section as is seen in Fig. 5.
In thie view, it is seen that the prosthesis 12 is positi~n-
ed in place with outer sac 16 surrounding inner core 13 and
~paced therefrom by the fluid or saline sQlution or absorb-
able sponge 17. The sac or container 16 is of an absorbable
material as described above and is in contact with the
ti~sue~ of the brea~t in the cavity formed in preparation
for ~n~tallation of the prcsthesis.
In Fig. 7, there i9 sh~wn a sectiQn of the same
~rea~t after the capsule ha~ formed as described for Fig. 2.
In this view, it is ~een ~hat the tis~ues forming capsule 5
form on the ~urface ~f sac or container 16 which is of an
ab~rbable material. Sac or container 16 is effective to
cause the capsule 5 to form at a substantial spacing from
inner core 13 as determined by the fluid 17 filling the
~pace around the core 13 inaide the outer sa~ 16.
In ~ig. 8, the section shown is similar to that in
Fig. 7 but represents the condition as it exists Yeveral
months later. At this time, inner cQre 13 occupies the ~ame
position as shown in Fig, 7. The outer ti~sue capsule 5 is
in sub~tantially the same position a~ shown in Fig. 7 or may
-have contracted sli~htly. The outer sac or container 16,
- ~5 -
~s:i~a~
however, has c~mpletely disappeared and has been absorbed
intc the b~dy tissues. The space between capsule 5 and
inner CQre 13 is ~ccupied by fluid material 17 which may be
the residue of the sQlutiQn c~ntained within outer sac or
c0ntainer 16 pri~r to its biological absorption ~r may be
bQdy fluid. In either case, the outer capsule ~ forms a
container or shell which fits l~sely around inner core 13
and the prosthesis does n~t have the tight, hard feel of a
pr~sthe~is which is tightly encapsulated as shown in Fig. 3.
In Fi8s. 11-13, there are shown embodiments in which
the inner permanent core itself c~nsists of a double lumen
c~nstruction of a type currently in use. Both lumens 14 and
14a of this structure are made ~f a non-absorbable material
~uch as silicQne rubber. The inner lumen 14a is filled with
a liquid such as n4rmal saline or a gel such as silicone gel
a9 indicated at l5. The outer lumen 14 is filled with a
compatible ~lution such as saline as indicated at 17a.
The entire double ~umen structure is ccntained,
covered or coated with an abscrbable material 16 whose outer
9urrace i at some predetermined distance from the outer
surface of the double lumen structure. The outer cover 16
preferably contains a liquid such as normal saline as
indicated at 17. In Fig. 13, the same structure is shown
except that the outer c~vering 16 does not cover the back of
the core and is sealed theret~ as indicated at 26. In Fig.
12, the prosthesis ~f Fig. 11 4r 13 i9 shown implanted in a
female breast.
The advantage of this particular embodiment is that
"bleeding" or leaking cf ~iliccne gel 15, if this material
19 used, from the inner lumen 14a will not c~me in ccntact
with the fibrous capsule. ~herefore further stimulation and
- 16 -
1~L9~L~0~
thickening of the fibrous capsule by the silicone gel
molecules will nct occur. Whatever leaking of the contents
of the inner lumen occurs will be trapped in the outer lumen
of the double lumen structure and will not reach the fibrous
.capsule tu cause further thickening,
_. .
J
_ 1~
